A. Radovic-Moreno

Molecular Biology · 2008–2012

A researcher in the Science corpus: 3 papers; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom A. Radovic-Moreno trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. O. Farokhzad (in Biomaterials)
  2. Robert Langer (in Molecular Biology)

Who trusts A. Radovic-Moreno

  1. O. Farokhzad (in Biomaterials)

Papers from A. Radovic-Moreno's perspective

Ordered by how strongly the researchers A. Radovic-Moreno trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Recent advances with liposomes as pharmaceutical carriers (Nature reviews. Drug discovery)
  2. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. (Progress in lipid research)
  3. Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies (Clinical Cancer Research)
  4. Long-circulating and target-specific nanoparticles: theory to practice. (Pharmacological Reviews)
  5. The emerging nanomedicine landscape (Nature Biotechnology)
  6. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers (Proceedings of the National Academy of Sciences of the United States of America)
  7. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. (Proceedings of the National Academy of Sciences of the United States of America)
  8. Polymer conjugates as anticancer nanomedicines (Nature Reviews. Cancer)
  9. Effect of pegylation on pharmaceuticals (Nature reviews. Drug discovery)
  10. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. (Journal of Controlled Release)

Their papers